期刊文献+

注射用英夫利西单抗联合肠内营养在克罗恩病治疗中的临床效果研究

Clinical study on the effect of remicade combined with intestinal nutrition and nursing in treatment of Crohn’s disease
下载PDF
导出
摘要 目的探讨注射用英夫利西单抗联合场内营养治疗克罗恩病的临床疗效。方法随机选取温州市中心医院2014年1月~2017年3月114例克罗恩病患者,并将所有患者随机分为2组,对照组采用常规的治疗,治疗组采用注射用英夫利西单抗治疗,比较2组患者的临床治疗效果,体质量、BMI和营养指标HB、ALB、ESR、CRP和CDAI变化。结果治疗组的BMI和体质量显著高于对照组(P<0.05)。治疗组HB,ALB显著高于对照组,治疗组ESR,CRP和CDAI水平显著低于对照组(P<0.05)。治疗组的总有效率为96.4%,高于对照组的总有效率70.7%(P<0.05)。结论注射用英夫利西单抗联合肠内营养治疗克罗恩病具有较好的临床治疗效果,改善患者的营养吸收。 Objective To investigate the effect of remicade combined with iintestinal nutrition and nursing on the treatment of Crohn’s disease.Methods114patients with Crohn’s disease from January2014to March2017were randomly divided into two groups.The control group was treated with conventional therapy.The treatment group was treated with two groups.The clinical efficacy,body mass,BMI and nutritional indicators of HB,ALB,ESR,CRP and CDAI were analyzed in the two groups.Results The levels of BMI and body weight in the treatment group were significantly higher than those in the control group(P<0.05).The levels of HB,ALB in the treatment group were significantly higher than those in the control group,ESR,CRP and CDAI in the treatment group were significantly lower than those in the control group(P<0.05).The total effective rate was96.4%in the treatment group,higher than70.7%in the control group(P<0.05).Conclusion The use of mannatide in children with recurrent respiratory tract infection to significantly improve the clinical efficiency,reduce the cough,sore throat and other symptoms of remission time,and the disease recurrence rate has been reduced,can greatly reduce the children’s pain.
作者 彭迎春 PENG Ying-chun(Department of Gastroenterology, Wenzhou Central Hospital, Wenzhou 325000, China)
出处 《中国生化药物杂志》 CAS 2017年第12期126-127,共2页 Chinese Journal of Biochemical Pharmaceutics
关键词 注射用英夫利西单抗 肠内营养 克罗恩病 remicade enteral nutrition Crohn’s disease
  • 相关文献

参考文献3

二级参考文献33

  • 1中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1020
  • 2Ye L, Cao Q, Cheng J. Review of inflammatory bowel disease in China[J/OL]. Scientific World Journal, 2013,2013 = 296470 [2013-09-26]. http: // www. hindawi, com/journals/tswj/ 2013/296470/. DOI:10. 1155/2013/296470.
  • 3Prideaux L, Kamm MA, De Cruz PP, et al. Inflammatory bowel disease in Asia.. a systematic review[J]. J Gastroenterol Hepatol, 2012, 27 (8), 1266-1280. DOI: 10. 1111/j. 1440- 1746. 2012. 07150. x.
  • 4Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults[J]. Gut, 2011,60(5) ~571-607. DOI: 10. 1136/gut. 2010. 224154.
  • 5Terdiman JP, Gruss CB, Heidelbaugh JJ, et al. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs /or the induction and maintenance of remission in inflammatory Crohn' s disease [J]. Gastroenterology, 2013, 145 (6): 1459-1463. DOI:]0. 1053/j. gastro. 2013.10. 047.
  • 6Feagan BG, Fedorak RN, Irvine EJ, et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohnrs disease. North American Crohn's Study Group Investigators[J]. N Engl J Med, 2000,342(22):1627-1632. DOI:10. 1056/NEJM200006013422202.
  • 7Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators[J].N Engl J Med, 1995, 332(5) :292-297. DOI: 10. 1056/NEJM199502023320503.
  • 8Ardizzone S, Bollani S, Manzionna G, et al. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohnrs disease a randomised, investigator- blind study[J]. Dig laver Dis,2003,35(9):619-627.
  • 9Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease controversies, consensus, and implications[J]. Gut, 2006,55(6):749-753.
  • 10Shah ED, Siegel CA, Chong K, et al. Patients with Crohn's disease are more likely to remain on biologics than immunomodulators: a recta-analysis of treatment durability [J]. Dig Dis Sei, 2015, 60(8):2408-2418. DOI: 10. 1007/ s10620-015 3618-8.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部